High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$645K
$645,902
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CRSP
S
CRISPR Therapeutics AG
KASINGER JAMES R.
• Officer • General Counsel and Secretary
Sell to Cover
2026-03-23
$148,854
|
||||||
| CRSP |
CRISPR Therapeutics AG
|
Officer • General Counsel and Secretary
Sell to Cover
|
2026-03-23 | $148,854 | S | Form 4 |
|
CRSP
S
CRISPR Therapeutics AG
KASINGER JAMES R.
• Officer • General Counsel and Secretary
Sell to Cover
2026-03-16
$166,497
|
||||||
| CRSP |
CRISPR Therapeutics AG
|
Officer • General Counsel and Secretary
Sell to Cover
|
2026-03-16 | $166,497 | S | Form 4 |
|
CRSP
S
CRISPR Therapeutics AG
KASINGER JAMES R.
• Officer • General Counsel and Secretary
Sell to Cover
2026-03-11
$147,840
|
||||||
| CRSP |
CRISPR Therapeutics AG
|
Officer • General Counsel and Secretary
Sell to Cover
|
2026-03-11 | $147,840 | S | Form 4 |
|
CRSP
S
CRISPR Therapeutics AG
KASINGER JAMES R.
• Officer • General Counsel and Secretary
Sell to Cover
2026-02-19
$111,049
|
||||||
| CRSP |
CRISPR Therapeutics AG
|
Officer • General Counsel and Secretary
Sell to Cover
|
2026-02-19 | $111,049 | S | Form 4 |
|
CRSP
S
CRISPR Therapeutics AG
KASINGER JAMES R.
• Officer • General Counsel and Secretary
Sell to Cover
2025-10-14
$71,662
|
||||||
| CRSP |
CRISPR Therapeutics AG
|
Officer • General Counsel and Secretary
Sell to Cover
|
2025-10-14 | $71,662 | S | Form 4 |